Arkolith/Insider Trading/BCYC/Form 4

Lee Kevin

CHIEF EXECUTIVE OFFICER, DirectorBICYCLE THERAPEUTICS PLC (BCYC) · full profile →Form 4 · filed Jan 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$141K
Net Open-Market Flow
-$141K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2026Sell(S)11K$6.46$71K619K
Jan 2, 2026Sell(S)10K$6.80$70K630K
Jan 2, 2026Grant(A)165K—$0640K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 2, 2026Grant(A)330K—$0330K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001776938-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML